Who owns ALZAMEND NEURO INC COM NEW 2025?

Tip: Access positions for across all investors

Analyze quarterly positions in Alzamend Neuro Inc Com New 2025 with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Alzamend Neuro Inc Com New 2025 stock

Who bought or sold ALZAMEND NEURO INC COM NEW 2025 this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Kingsbury Capital Investment Advisors 1.3M $1.6M 135% Jun 2026
 View chart
Kmt Wealth Management 1.3M $1.6M 100% Jun 2026
 View chart
Geode Capital Management 26k $32k -42% Jun 2026
 View chart
Vanguard Fiduciary Trust 21k $25k 0% Jun 2026
 View chart
Morgan Stanley 18k $19k 0% Mar 2026
 View chart
Vanguard Capital Management 7.6k $9.1k 72% Jun 2026
 View chart
Citigroup 5.2k $5.5k 100% Mar 2026
 View chart
Tower Research Capital 3.5k $4.2k -43% Jun 2026
 View chart
UBS Group 2.4k $2.8k -48% Jun 2026
 View chart
BlackRock 437.00 $524.006700 0% Jun 2026
 View chart
SBI Securities 22.00 $25.999600 0% Jun 2026
 View chart
IFG Advisory 22.00 $25.999600 100% Jun 2026
 View chart
Caitong International Asset Management 3.00 $3.999900 -25% Jun 2026
 View chart
Harbor Investment Advisory 1.00 $1.000000 0% Jun 2026
 View chart

Who sold out of Alzamend Neuro Inc Com New 2025?

Fund or Company Name Date Sold Shares Held Valued At
Hartland & Co Mar 2026 10k $11k